36 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32207094 | Certolizumab Pegol: A Review in Moderate to Severe Plaque Psoriasis. | 2020 Apr | 2 |
2 | 33116155 | Improvement of Certolizumab Fab' properties by PASylation technology. | 2020 Oct 28 | 1 |
3 | 27567553 | Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists. | 2018 Jan | 1 |
4 | 29860435 | TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism. | 2018 Aug 29 | 1 |
5 | 28124979 | Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases. | 2017 Jan 23 | 1 |
6 | 28712320 | Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study. | 2017 Nov | 2 |
7 | 27464588 | Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials. | 2016 Dec | 1 |
8 | 25586216 | Evaluation of pharmacokinetics and pharmacodynamics and clinical efficacy of certolizumab pegol for Crohn's disease. | 2015 Feb | 1 |
9 | 26316054 | Safety Profile of Certolizumab Pegol in Patients with Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-Analysis. | 2015 Oct | 2 |
10 | 24687236 | Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice. | 2014 Apr | 1 |
11 | 23620660 | Profile of certolizumab and its potential in the treatment of psoriatic arthritis. | 2013 | 2 |
12 | 23752881 | Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease. | 2013 Sep | 1 |
13 | 22413944 | Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension. | 2012 Jul | 1 |
14 | 21507990 | The use of surrogate antibodies to evaluate the developmental and reproductive toxicity potential of an anti-TNFalpha PEGylated Fab' monoclonal antibody. | 2011 Jul | 3 |
15 | 21642014 | Certolizumab pegol for active Crohn's disease: a placebo-controlled, randomized trial. | 2011 Aug | 2 |
16 | 21794764 | [Certolizumab pegol]. | 2011 Mar | 1 |
17 | 27790005 | Certolizumab in the long-term treatment of rheumatoid arthritis. | 2011 | 1 |
18 | 19885906 | Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. | 2010 May | 1 |
19 | 20096379 | Correlation between the Crohn's disease activity and Harvey-Bradshaw indices in assessing Crohn's disease severity. | 2010 Apr | 1 |
20 | 20674798 | Pulmonary infectious complications of tumor necrosis factor blockade. | 2010 Sep | 1 |
21 | 21079302 | Golimumab and certolizumab: the two new anti-tumor necrosis factor kids on the block. | 2010 Nov-Dec | 1 |
22 | 22915918 | Prefilled certolizumab pegol (Cimzia(®)) syringes for self-use in the treatment of rheumatoid arthritis. | 2010 | 2 |
23 | 19222517 | New biologics for psoriasis and psoriatic arthritis. | 2009 Jan-Feb | 1 |
24 | 19491672 | Infectious complications of tumor necrosis factor blockade. | 2009 Aug | 1 |
25 | 19894782 | Certolizumab pegol: in rheumatoid arthritis. | 2009 | 1 |
26 | 20477691 | Certolizumab pegol for the treatment of Crohn's disease. | 2009 Nov | 1 |
27 | 21694828 | New biologics in the management of Crohn's disease: focus on certolizumab pegol. | 2009 | 1 |
28 | 19180261 | Certolizumab pegol in Crohn's disease. | 2008 Nov | 1 |
29 | 21221187 | Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn's disease. | 2008 Feb 29 | 2 |
30 | 17516714 | Certolizumab pegol: in Crohn's disease. | 2007 | 1 |
31 | 17634458 | Certolizumab pegol for the treatment of Crohn's disease. | 2007 Jul 19 | 1 |
32 | 17634459 | Maintenance therapy with certolizumab pegol for Crohn's disease. | 2007 Jul 19 | 1 |
33 | 17722511 | Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870). | 2007 | 2 |
34 | 20477019 | Treatment of Crohn's disease with certolizumab pegol. | 2007 Sep | 3 |
35 | 15934837 | CDP-870 (certolizumab) in rheumatoid arthritis. | 2005 Apr | 1 |
36 | 15606396 | Intravenous CDP870, a PEGylated Fab' fragment of a humanized antitumour necrosis factor antibody, in patients with moderate-to-severe Crohn's disease: an exploratory study. | 2004 Dec | 1 |